Featured Research

from universities, journals, and other organizations

Scientists Locate A Genetic 'On/Off Switch' In Diphtheria; Find May Yield Antibiotics That Won't Boost Bacterial Resistance

Date:
November 6, 1998
Source:
Brandeis University
Summary:
Researchers at Brandeis University and the Boston University School of Medicine have pinpointed a genetic repressor that can single-handedly morph diphtheria from a mild-mannered bacterium into a lethal parasite. This tiny complex could prove to be the Achilles' tendon of resistant strains of killers such as diphtheria, staph, and flesh-eating bacteria, opening them up to a new class of drugs that won't induce resistance.

WALTHAM, Mass. -- Researchers at Brandeis University and the Boston University School of Medicine have pinpointed a genetic repressor that can single-handedly morph diphtheria from a mild-mannered bacterium into a lethal parasite. This tiny complex could prove to be the Achilles' tendon of resistant strains of killers such as diphtheria, staph, and flesh-eating bacteria, opening them up to a new class of drugs that won't induce resistance.

Related Articles


The work of the team led by Dagmar Ringe, professor of biochemistry at Brandeis' Rosenstiel Basic Medical Sciences Research Center, appeared in a recent issue of Nature.

Ringe's mapping of the structure of the powerful yet minuscule DtxR repressor -- a billion billion of which could fit on the head of a pin -- doesn't offer insights solely into diphtheria, where DtxR functions. "DtxR is a prototype for the activity of many other virulent bacteria," she says. "Most pathogenic bacteria, including those responsible for tetanus, syphilis, tuberculosis, and botulism, have their own versions of this repressor."

Scientists have known for some time that these bacteria somehow rely on metal ions to become virulent, but the exact mechanism has remained elusive. Ringe and her colleagues used X-ray crystallography to unmask, atom by atom, the exact structure of DtxR, which holds the key to diphtheria's Jekyll-and-Hyde behavior. They found that this repressor, normally tightly latched to the bacterial DNA, has two binding sites for iron ions; when iron grows scarce, the repressor falls off the DNA strand, allowing expression of a gene that goads the bacterium into attacking its host's cells.

"Until now, nobody knew just how bacteria translated a shortage of iron into a headlong assault on the body's tissues," Ringe says.

This chain of events is part of the battle our immune system regularly fights with a variety of pernicious bacteria. Upon recognizing that iron-craving bacteria are infiltrating the body, the liver responds by sequestering iron. The battle then escalates, with the bacteria retaliating by attacking the body's cells in the hope of scavenging some iron.

Scientists say the new findings raise the prospect of a novel class of antibiotics that won't foster bacterial resistance; current-generation treatments can lead to resistance in as little as six months. "Today's antibiotics actually strengthen resistant strains of bacteria," notes Gregory Petsko, Gyula and Katica Tauber Professor of Biochemistry and Molecular Pharmacodynamics and director of the Rosenstiel Center at Brandeis. "When they kill off normal strains while leaving resistant strains unaffected, they're essentially selecting for the resistant strains' survival."

"The potential new class of drugs here would be better because rather than killing the bacteria, theyΉd simply prevent the bacteria from becoming virulent and killing you," adds Petsko, who was not involved in this work.

Once 95 percent lethal, diphtheria is no longer a major concern in the developed world. But the former Soviet Union has experienced a sharp recurrence of the disease during the 1990s, and public health officials are watching with alarm as the outbreak trudges westward toward Europe.

Ringe was joined in the work by Andre White and Xiaochun Ding at Brandeis and Johanna C. vanderSpek and John R. Murphy at Boston University. The research was sponsored by the National Institute of Allergy and Infectious Diseases and the Lucille P. Markey Charitable Trust.


Story Source:

The above story is based on materials provided by Brandeis University. Note: Materials may be edited for content and length.


Cite This Page:

Brandeis University. "Scientists Locate A Genetic 'On/Off Switch' In Diphtheria; Find May Yield Antibiotics That Won't Boost Bacterial Resistance." ScienceDaily. ScienceDaily, 6 November 1998. <www.sciencedaily.com/releases/1998/11/981106081451.htm>.
Brandeis University. (1998, November 6). Scientists Locate A Genetic 'On/Off Switch' In Diphtheria; Find May Yield Antibiotics That Won't Boost Bacterial Resistance. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/1998/11/981106081451.htm
Brandeis University. "Scientists Locate A Genetic 'On/Off Switch' In Diphtheria; Find May Yield Antibiotics That Won't Boost Bacterial Resistance." ScienceDaily. www.sciencedaily.com/releases/1998/11/981106081451.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) — A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) — Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) — A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) — Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins